CorVel Corporation (NASDAQ:CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs.

As medical billing continues to vary widely across states, providers, and care settings, traditional network and re-pricing approaches do not always reflect market pricing. Marketwise Repricing addresses this by integrating market-based reimbursement methods within CorVel's existing bill review workflow. This approach captures additional savings that traditional bill review methods may miss, ultimately reducing overall medical spend.